JAMA | The Latest Medical Research, Reviews, and Guidelines Follow Nicotinamide Riboside for Patients With Early-Stage Parkinson Disease This randomized trial assesses the effect of oral nicotinamide riboside treatment for 52 weeks vs placebo on clinical outcomes among patients with early Parkinson disease. https://jamanetwork.com/journals/jama/fullarticle/2855023 jamanetwork.com